| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |